title: Reply to Azuaje: Predicting effective combined therapies for heterogeneous tumors.
authors.affiliation: Computational and Systems Biology Program, The David H. Koch Institute for Integrative Cancer Research, and.
authors.forename: Boyang
authors.initials: B
authors.lastname: Zhao
authors.affiliation: The David H. Koch Institute for Integrative Cancer Research, and Departments of Biology and.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Hemann
authors.affiliation: The David H. Koch Institute for Integrative Cancer Research, and Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 lauffen@mit.edu.
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Lauffenburger
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018740:Genetic Heterogeneity; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents